Fig. 5From: APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potentialActivation of APOBEC3s to enhance response to immunotherapy. Increasing APOBEC3 activity could increase immunotherapy response through neoepitope formation, increased PD-L1 expression, and immune activation as has been demonstrated by studies using mouse modelsBack to article page